Search research articles
Contact Us
Filters
Showing results (71-80 of 105) with videos related to
Page
of 11
Sort By:
Frontiers in Psychiatry
|
December 6, 2018
Bringing an Effective Behavioral Weight Loss Intervention for People With Serious Mental Illness to Scale
Emma E McGinty, Kimberly A Gudzune, Arlene Dalcin, et al.
Stroke
|
June 1, 2013
Stroke patients develop antibodies that react with components of N-methyl-D-aspartate receptor subunit 1 in proportion to lesion size
Maggie L Kalev-Zylinska, Wymond Symes, Kevin C E Little, et al.
Pediatric Diabetes
|
November 17, 2009
Psychological symptoms and insulin sensitivity in adolescents
Lauren B Shomaker, Marian Tanofsky-Kraff, Deborah Young-Hyman, et al.
ISRN Neuroscience
|
June 27, 2014
An Immunological Approach to Increase the Brain's Resilience to Insults
En-Ju D Lin, C Wymond Symes, Andrea Townsend-Nicholson, et al.
Molecular Neurodegeneration
|
June 15, 2007
Novel rat Alzheimer's disease models based on AAV-mediated gene transfer to selectively increase hippocampal Abeta levels
Patricia A Lawlor, Ross J Bland, Pritam Das, et al.
Journal of Translational Medicine
|
April 28, 2010
Correlation of pharmacodynamic activity, pharmacokinetics, and anti-product antibody responses to anti-IL-21R antibody therapeutics following IV administration to cynomolgus monkeys
Yulia Vugmeyster, Scott Allen, Pamela Szklut, et al.
Journal of Huntington'S Disease
|
May 4, 2026
Development-related gene expression disruption in the human midcingulate cortex in Huntington's disease
Shelly Scheepers, Mackenzie W Ferguson, Thulani H Palpagama, et al.
Plos One
|
December 21, 2013
Interleukin-21 receptor signalling is important for innate immune protection against HSV-2 infections
Sine K Kratholm, Marie B Iversen, Line Reinert, et al.
Lancet (London, England)
|
June 26, 2007
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial
Michael G Kaplitt, Andrew Feigin, Chengke Tang, et al.
Molecular Therapy. Oncology
|
May 11, 2026
AAV transduction of human glioblastoma cell lines induces perturbation in cell proliferation
Angela Wu, Carina J Dumo, William H Cook, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 105) with videos related to
Sort By:
Page
of 11
Frontiers in Psychiatry
|
December 6, 2018
Bringing an Effective Behavioral Weight Loss Intervention for People With Serious Mental Illness to Scale
Emma E McGinty, Kimberly A Gudzune, Arlene Dalcin, et al.
Stroke
|
June 1, 2013
Stroke patients develop antibodies that react with components of N-methyl-D-aspartate receptor subunit 1 in proportion to lesion size
Maggie L Kalev-Zylinska, Wymond Symes, Kevin C E Little, et al.
Pediatric Diabetes
|
November 17, 2009
Psychological symptoms and insulin sensitivity in adolescents
Lauren B Shomaker, Marian Tanofsky-Kraff, Deborah Young-Hyman, et al.
ISRN Neuroscience
|
June 27, 2014
An Immunological Approach to Increase the Brain's Resilience to Insults
En-Ju D Lin, C Wymond Symes, Andrea Townsend-Nicholson, et al.
Molecular Neurodegeneration
|
June 15, 2007
Novel rat Alzheimer's disease models based on AAV-mediated gene transfer to selectively increase hippocampal Abeta levels
Patricia A Lawlor, Ross J Bland, Pritam Das, et al.
Journal of Translational Medicine
|
April 28, 2010
Correlation of pharmacodynamic activity, pharmacokinetics, and anti-product antibody responses to anti-IL-21R antibody therapeutics following IV administration to cynomolgus monkeys
Yulia Vugmeyster, Scott Allen, Pamela Szklut, et al.
Journal of Huntington'S Disease
|
May 4, 2026
Development-related gene expression disruption in the human midcingulate cortex in Huntington's disease
Shelly Scheepers, Mackenzie W Ferguson, Thulani H Palpagama, et al.
Plos One
|
December 21, 2013
Interleukin-21 receptor signalling is important for innate immune protection against HSV-2 infections
Sine K Kratholm, Marie B Iversen, Line Reinert, et al.
Lancet (London, England)
|
June 26, 2007
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial
Michael G Kaplitt, Andrew Feigin, Chengke Tang, et al.
Molecular Therapy. Oncology
|
May 11, 2026
AAV transduction of human glioblastoma cell lines induces perturbation in cell proliferation
Angela Wu, Carina J Dumo, William H Cook, et al.
Page
of 11